Concept Lead score
Myasthenia Gravis 1 1
Immunoglobulin G (IgG) 0 0.63
Biologic Therapy 0 0.53
Muscular Atrophy 0 0.51
Quality of Life 0 0.39
Receptors 0 0.39
Targeted Cancer Therapy 0 0.39
Refractory 0 0.29
Patient Safety 0 0.26
Skeletal Myoblasts 0 0.21
Food and Drug Administration (FDA) 0 0.2
Muscle 0 0.2
Otolaryngology 0 0.19
Upper Respiratory Tract Infection 0 0.14
Depression 0 0.13
Diarrhea 0 0.13
Headache 0 0.13
Muscular Dystrophy 0 0.13
Urinary Tract Infection 0 0.13
Adenocarcinoma 0 0.1
Adverse Effects 0 0.1
Autoimmune Disease 0 0.1
Blood 0 0.1
Europe 0 0.1
Immunoglobulin A (IgA) 0 0.1
Match 0 0.1
Nausea 0 0.1
Neuromuscular Diseases 0 0.1
Prescription Drugs 0 0.1
Respiratory Tract 0 0.1
Thrombocytosis 0 0.1
Weakness 0 0.1
Specialty Lead score
Pharmacist 1 0.7
Family Medicine/Primary Care 0 0.7
Internal Medicine 0 0.88
Neurology & Neurosurgery 0 1
Hematology-Oncology 0 0.66